Press Releases

Current Articles | Categories | Search | Syndication

22 April 2014  Joanne Hunter
EKF Diagnostics Acquires Selah Genomics, Inc. and DiaSpect Medical AB
By Joanne Hunter @ 12:19 :: 10 Views

Cardiff, UK – 22 April 2014 – EKF Diagnostics (www.ekfdiagnostics.com), the global in vitro diagnostics business, announces that it has acquired Selah Genomics, Inc. and DiaSpect Medical AB. Sweden based DiaSpect manufactures desktop hemoglobin analyzers, whilst Selah, of South Carolina is a service provider that supplies molecular diagnostics tests for the development of personalized medicine.

Read More

22 April 2014  Joanne Hunter
Oxford Immunotec receives 2014 Queen’s Award for Enterprise
By Joanne Hunter @ 09:57 :: 15 Views

OXFORD, UK and MARLBOROUGH, MA, APR. 21, 2014 (GLOBE NEWSWIRE) – Oxford Immunotec Global PLC (NASDAQ: OXFD) today announced that it has received a Queen’s Award for Enterprise – the UK’s highest accolade in business success.

Read More

22 April 2014  Joanne Hunter
Roche widens serology portfolio with new Elecsys® Syphilis test
By Joanne Hunter @ 09:09 :: 14 Views

Roche is pleased to announce the launch of the Elecsys® Syphilis test.  The new Elecsys assay enables the detection of total antibodies to T. pallidum (detection of IgG & IgM antibodies against TpN15, TpN17 & TpN47) and complements the Mediace® Rapid Plasma Reagin (RPR) and T. pallidum Latex Agglutination® (TPLA) Roche assays, allowing reliable detection of infection and treatment monitoring for syphilis

Read More

11 April 2014  Rachel Myers
Breakthrough technology to enable doctors to select more effective treatment for cancer patients on a personalised basis.
By Rachel Myers @ 15:17 :: 117 Views



11th April 2014, Cobham, UK. -- The possibility of patients with pancreatic cancer being able to have their cancer tissue ‘profiled’ to understand how they will react to different treatments before they are given to them has moved a lot closer, a new research paper shows, published in the peer reviewed journal PLOS ONE. This will enable more accurate profiling and the best drug selection for each individual. Trials are being planned to undertake the final stage of the process. 

Read More

08 April 2014  Rachel Myers
Siemens Healthcare Diagnostics leads the way with standardisation of Vitamin D assay
By Rachel Myers @ 11:03 :: 135 Views



Siemens Healthcare Diagnostics has become the first manufacturer to gain standardisation of its ADVIA Centaur® Vitamin D Total assay to the National Institute of Standards and Technology - Ghent University Reference Measurement Procedure based on isotope-dilution liquid chromatography-tandem mass spectrometry. 

Read More

02 April 2014  Rebecca Bellars
EKF Diagnostics has acquired Separation Technology
By Rebecca Bellars @ 16:16 :: 139 Views



EKF Diagnostics (www.ekfdiagnostics.com), the global in vitro diagnostics business, announces that it has acquired Separation Technology, Inc. (STI), the Florida based manufacturer of in vitro diagnostics devices for hematology testing. 

Read More

01 April 2014  Joanne Hunter
Coming out of the Cold with Stat-Nat® Thermally Stable PCR Master Mix
By Joanne Hunter @ 10:48 :: 165 Views


Now available in the UK from Alpha Laboratories (Eastleigh, Hants), STAT-NAT® is a new protective compound that stabilises the activity of enzymes for a very long time with no temperature controlled storage requirements. This proprietary technology developed by Sentinel (Milan, Italy), provides an optimal and convenient basic platform useful for kits, “home brew” routine tests, and for the development of new assays.

Read More

27 March 2014  Joanne Hunter
SysQuant® - Pancreatic Cancer Study in PLOS ONE
By Joanne Hunter @ 10:56 :: 154 Views

27th March, 2014 – The SysQuant® study addressing pancreatic cancer published yesterday in PLOS ONE provides a helicopter view over cell signalling pathways that elegantly demonstrates Proteome Sciences ability to measure the phosphorylation status and expression of very important drug targets and many other signalling proteins. This technology is equally applicable to all cancers. With our collaborators at King’s College Hospital, London SysQuant® identified a number of novel potential therapeutic targets and new diagnostic and prognostic biomarkers covered by patent applications.

Read More

26 March 2014  Joanne Hunter
Liver disease - simple test available could save lives says expert
By Joanne Hunter @ 15:20 :: 160 Views


Please find below industry commentary from Siemens Healthcare responding to the report from the all-party Parliamentary Hepatology Group outlining how deaths from liver disease in England have risen by 40% between 2001-2012:

Read More

26 March 2014  Joanne Hunter
AACR 2014 – EKF Molecular Highlights Ultra-Sensitive Cancer Mutation Detection Kits
By Joanne Hunter @ 08:41 :: 206 Views

Cardiff, UK – 25th March 2014 – EKF Diagnostics (www.ekfdiagnostics.com), the global in vitro diagnostics business, will be present on Booth #438 at AACR 2014 (American Association of Cancer Research), 5-9th April, San Diego. EKF Molecular will exhibit its PointMan™ DNA-enrichment technology which enables ultra-sensitive and highly-specific cancer mutation detection unmatched by existing technologies.

Read More

Previous Page | Next Page